Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER × oregovomab × Clear all

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

NIH 2 OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Ovarian Epithelial 1

Interventions

Cisplatin 318 Capecitabine 234 Oxaliplatin 233 Radiotherapy 217 Carboplatin 202 Docetaxel 201 Cyclophosphamide 193 Gemcitabine 192 apatinib 190 Paclitaxel 182 Drug Therapy 179 Bevacizumab 174 Fluorouracil 169 camrelizumab 168 Blood Specimen Collection 118 Irinotecan 113 sintilimab 111 Dexamethasone 109 Etoposide 104 toripalimab 101 Radiosurgery 99 Surgical Procedures, Operative 98 Pemetrexed 95 S 1 (combination) 94 pembrolizumab 93 anlotinib 91 Surveys and Questionnaires 88 Leucovorin 88 Rituximab 87 Nivolumab 87

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04620954 2021-12-01

ORION-02

National Cancer Centre, Singapore

Phase 1/2 Unknown

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡